1. Home
  2. VYGR vs ZSQR Comparison

VYGR vs ZSQR Comparison

Compare VYGR & ZSQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$3.40

Market Cap

216.3M

Sector

Health Care

ML Signal

N/A

Logo Z Squared Inc. Common Stock

ZSQR

Z Squared Inc. Common Stock

N/A

Current Price

$3.09

Market Cap

204.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VYGR
ZSQR
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
216.3M
204.6M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
VYGR
ZSQR
Price
$3.40
$3.09
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
404.1K
303.4K
Earning Date
05-08-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.27
EPS
N/A
N/A
Revenue
$10,135,000.00
$1,363,045.00
Revenue This Year
$34.04
N/A
Revenue Next Year
$7.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.94
$2.81
52 Week High
$5.55
$16.62

Technical Indicators

Market Signals
Indicator
VYGR
ZSQR
Relative Strength Index (RSI) 56.22 33.59
Support Level $3.33 N/A
Resistance Level $3.56 $4.38
Average True Range (ATR) 0.16 0.46
MACD 0.01 0.07
Stochastic Oscillator 74.03 15.53

Price Performance

Historical Comparison
VYGR
ZSQR

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

About ZSQR Z Squared Inc. Common Stock

Z Squared Inc is a computing infrastructure company operating computing equipment and expanding into AI infrastructure. The Company's idea is to build on three principles: guide with power by acquiring operating sites where power is already flowing; build for AI workloads by converting that capacity into AI-ready colocation where the customer brings the compute and runs what it needs; and scale with discipline by deploying conversion capital site by site, against signed contracts and operational readiness.

Share on Social Networks: